Clinical Trials Insight: 700028883
Phase of Trial: Phase I
Latest Information Update: 28 Nov 2007
At a glance
- Drugs Auriclosene (Primary)
- Indications Conjunctivitis; Otorhinolaryngological infections; Staphylococcal infections; Urinary tract infections
- Focus Adverse reactions
- Sponsors NovaBay Pharmaceuticals
- 28 Nov 2007 Results have been reported by NovaBay Pharmaceuticals.
- 28 Nov 2007 New trial record.